Skip to main content
BK
NYSE Finance

BNY Mellon Reports Strong Q4 & Full-Year 2025 Results, Raises Medium-Term Targets

KI-Analyse von Wiseek
Stimmung info
Positiv
Wichtigkeit info
8
Preis
$120.66
Marktkapitalisierung
$84.142B
52W Tief
$70.46
52W Hoch
$122.36
Market data snapshot near publication time

summarizeZusammenfassung

The Bank of New York Mellon's latest earnings report signals robust financial health and strategic momentum. The significant year-over-year growth in both quarterly and full-year revenue and EPS, coupled with strong profitability metrics like ROTCE and pre-tax margin, indicates effective operational management. The company's ability to generate substantial capital returns through dividends and share repurchases further underscores its financial strength. The positive 2026 outlook and the upward revision of medium-term financial targets suggest management's confidence in sustained performance and growth, which is particularly noteworthy as the stock trades near its 52-week high. Investors should view this report as a strong affirmation of the company's strategic transformation and future earnings potential.


check_boxSchlusselereignisse

  • Strong Q4 and Full-Year 2025 Performance

    Reported diluted EPS of $2.02 for Q4 (up 31% YoY) and $7.40 for full-year 2025 (up 28% YoY), alongside revenue growth of 7% and 8% respectively.

  • Increased Profitability and Efficiency

    Achieved a 36% pre-tax operating margin and 26.6% Return on Tangible Common Equity (ROTCE) in Q4, driven by positive operating leverage.

  • Robust Capital Returns

    Returned $1.4 billion to common shareholders in Q4, including $1.0 billion in share repurchases, contributing to a 94% total payout ratio for full-year 2025.

  • Positive 2026 Outlook and Raised Medium-Term Targets

    Forecasts 5% +/- YoY revenue growth and 3-4% YoY expense growth (excluding notable items) for 2026, and set new medium-term targets for pre-tax margin (>=33%) and ROTCE (>=28%).


auto_awesomeAnalyse

The Bank of New York Mellon's latest earnings report signals robust financial health and strategic momentum. The significant year-over-year growth in both quarterly and full-year revenue and EPS, coupled with strong profitability metrics like ROTCE and pre-tax margin, indicates effective operational management. The company's ability to generate substantial capital returns through dividends and share repurchases further underscores its financial strength. The positive 2026 outlook and the upward revision of medium-term financial targets suggest management's confidence in sustained performance and growth, which is particularly noteworthy as the stock trades near its 52-week high. Investors should view this report as a strong affirmation of the company's strategic transformation and future earnings potential.

Zum Zeitpunkt dieser Einreichung wurde BK bei 120,66 $ gehandelt an der NYSE im Sektor Finance, bei einer Marktkapitalisierung von rund 84,1 Mrd. $. Die 52-Wochen-Handelsspanne lag zwischen 70,46 $ und 122,36 $. Diese Einreichung wurde mit positiver Marktstimmung und einem Wichtigkeitsscore von 8 von 10 bewertet.

descriptionHaupt-SEC-Einreichung ansehen

show_chartPreisdiagramm

Diesen Artikel teilen

Copied!

feed BK - Neueste Einblicke

BK
Apr 23, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
BK
Apr 16, 2026, 8:35 PM EDT
Filing Type: FWP
Importance Score:
7
BK
Apr 16, 2026, 8:33 PM EDT
Filing Type: FWP
Importance Score:
7
BK
Apr 16, 2026, 6:31 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
BK
Apr 16, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
9
BK
Mar 05, 2026, 4:39 PM EST
Filing Type: 8-K
Importance Score:
7
BK
Feb 26, 2026, 5:00 PM EST
Filing Type: FWP
Importance Score:
7
BK
Feb 25, 2026, 7:31 AM EST
Filing Type: 10-K
Importance Score:
8
BK
Jan 22, 2026, 4:44 PM EST
Filing Type: 8-K
Importance Score:
7
BK
Jan 14, 2026, 7:58 PM EST
Filing Type: FWP
Importance Score:
8